Isotretinoin Actavis

Isotretinoin, the active ingredient in Isotretinoin Actavis, is a retinoid presented as an oral capsule for oral use. It is indicated for the treatment of severe recalcitrant nodular acne in patients who have not responded adequately to conventional therapies. It is marketed throughout the European Union.

GNH USA supplies Isotretinoin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for import and distribution across multiple regions.

Isotretinoin is a systemic retinoid that is employed for the management of severe, treatment‑resistant acne conditions.

Severe recalcitrant nodular acne: reduces inflammatory lesions and prevents formation of new nodules. Severe cystic acne: diminishes cystic lesions and improves overall skin appearance. Acne unresponsive to conventional therapy: provides an effective option when other treatments have failed.

Isotretinoin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry skin and mucous membranes - Cheilitis (cracked lips) - Dry eyes or irritation - Photosensitivity to sunlight - Elevated triglyceride levels - Musculoskeletal aches or joint pain

Serious or Rare Side Effects: - Severe depression or suicidal ideation - Inflammatory bowel disease flare - Hepatotoxicity with elevated liver enzymes - Pseudotumor cerebri (increased intracranial pressure) - Teratogenic effects causing fetal malformations - Severe hypercalcemia

When prescribing Isotretinoin, clinicians should observe several safety precautions to minimize risks.

Pregnancy contraindication: avoid use in pregnant women due to high teratogenic risk. Teratogenic risk: enforce effective contraception for females of child‑bearing potential. Liver function monitoring: assess hepatic enzymes before and during therapy. Lipid level monitoring: check serum triglycerides and cholesterol regularly. Avoid vitamin A supplementation: excess retinoids increase toxicity. Use effective contraception: combined oral contraceptives or other approved methods throughout treatment and for one month after. Store at ambient temperature: keep in the original pack, protect from moisture.

Isotretinoin can interact with other medicines, affecting its safety or effectiveness.

Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of intracranial hypertension. - Vitamin A supplements: additive retinoid toxicity. - Concurrent systemic retinoids (e.g., acitretin): cumulative teratogenic risk.

Moderate Interactions (Monitor Closely): - Combined oral contraceptives: may reduce contraceptive efficacy. - Corticosteroids: heightened risk of pseudotumor cerebri. - Enzyme‑inducing agents (e.g., phenobarbital): may lower isotretinoin plasma concentrations.